Fixing Healthcare Podcast
FHC #110: Diving deep into drug-pricing wizardry and deep learning (AI)
Oct 25, 2023
In this episode, Dr. Robert Pearl and Jeremy Corr discuss the deceptive tactics used by drug companies to justify high prices and the impact on patient care. They also explore the transformative potential of generative AI in healthcare and its ability to democratize medical knowledge. AI tools like ChatGPT are expected to radically change healthcare, empower patients, and redefine the doctor-patient relationship. Find out more in this intriguing episode.
34:27
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The US biopharmaceutical industry uses deceptive tactics to maintain high drug prices, leading to massive profits and hindering affordable healthcare for Americans.
- Generative AI has the potential to revolutionize healthcare by democratizing medical knowledge, surpassing doctors' accuracy, and empowering patients.
Deep dives
The Illusion of Drug Company Pricing
The podcast episode explores the deceptive tactics used by the US biopharmaceutical industry in response to the possibility of lower drug prices. It reveals that exorbitant pricing is the industry's primary strategy, leading to massive profits. Lower prices would not hinder drug discovery or patient care as claimed. The profitability of drug companies is largely driven by corporate profits, not research and development. The legislation to reduce drug prices would greatly benefit patients and reduce the federal deficit.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
